FREE hit counter and Internet traffic statistics from freestats.com
NEWS
>
Press Releases


April 5, 2016 - FIT Biotech Oy: Finnish FIT Biotech and US Ichor to collaborate on new cost effective infectious disease treatment
View Release

June 2, 2015 - Ichor partner Scancell Announces Update on SCIB1 Phase 1/2 Clinical Trial in Stage III and IV melanoma patients
View Release

April 13, 2015 - Ichor Medical Systems Announces Strategic Collaboration with Johnson & Johnson Innovation to Develop and Commercialize Immunotherapies Delivered with TriGrid Electroporation Device for Chronic Hepatitis B
View Release

November 17, 2014 - Ichor Medical Systems Awarded DARPA Contract for Development of TriGrid Platform for Passive Immunization
View Release

June 2, 2014 - Update on Phase 1/2 clinical trial of SCIB1 in Stage III/IV melanoma
View Release

May 7, 2014 - Flextronics Partners with Ichor Medical Systems to Provide Supply Chain Solutions, Including Design and Manufacturing Services
View Release

February 5, 2014 - Ichor Enters into an Agreement with Pfizer to Develop Electroporation Devices for Use in Therapeutic Cancer Vaccine Regimens
View Release

April 30, 2013 - Ichor Medical Systems Awarded Contract for Further Development of Broad Vaccine for Biodefense Pathogens
View Release

December 6, 2012 - Ichor partner Scancell Announces Update on SCIB1 Phase 1/2 Clinical Trial Preliminary Evidence of Immune Response and Clinical Benefit
View Release

May 17, 2012 - Medical Device and Diagnostic Expo a Big Hit
View Release

December 19, 2011 - IAVI and Partners Initiate AIDS Vaccine Trial in Africa
View Release

April 18, 2011 - US Department of Defense Awards Grant to Ichor Medical Systems to Evaluate Skin Electroporation Device for Delivery of Multi-agent DNA Vaccines
View Release

January 5, 2011 - Profectus Biosciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
View Release

September 23, 2010 - Vaxonco's EP1300 Epitope-Based DNA Vaccine for Malaria Delivered by Ichor's TriGridô Electroporation Enters Phase I Trial
View Release

July 26, 2010 - Ichor Medical Systems Awarded Contract to Further Development of Vaccine for Biodefense Pathogen
View Release

June 15, 2010 - SCIB1 Phase I Trial Commences - First Patient Treated
View Release

May 5, 2010 - Clinical Trial Approval for SCIB1 Melanoma Vaccine Study
View Release

March 2, 2010 - Ichor Medical Systems and Profectus Biosciences Enter into an Agreement for Use of TriGrid Electroporation Device to Develop Multiple DNA Vaccines
View Release

February 2, 2010 - Clinical Trial Application for SCIB1 melanoma vaccine
View Release

November 30, 2009 - Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses when the Vaccine is Delivered by Electrical Impulses
View Release

August 5, 2009 - Ichor Medical Systems Awarded $3.3 Million NIH Grant to Develop Alzheimer's Disease Vaccine
View Release

July 16, 2009 - Scancell Licenses TriGridô Electroporation Device from Ichor Medical Systems
View Release

October 17, 2008 - Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichorís TriGrid to be Presented at AIDS Conference
View Release

March 10, 2008 - Pharmexa and Ichor Medical Systems Enter into an Agreement to Co-develop Multiple DNA Vaccines Delivered by Electroporation
View Release

March 4, 2008 - Ichor Melanoma Vaccine Clinical Trial Moves to the Highest Dose Level
View Release

October 1, 2007 - Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine
View Release

August 6, 2007 - Navy Partners with Ichor Medical Systems to Develop a Vaccine for Anthrax and Plague
View Release

June 18, 2007 - Ichor Medical Systems Selects Gable PR
View Release

May 14, 2007 - FDA Approves Phase I Clinical Trial Using Ichor's TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering
View Release

March 26, 2007 - Interferon Beta DNA Treatment Delivered with Ichor Technology Reduces Atherosclerosis Progression in Mice
View Release

March 5, 2007 - United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
View Release

December 18, 2006 - Pharmexa-Epimmune and Ichor Medical Systems Enter into a Collaborative Agreement
View Release

August 24, 2005 - Ichor Medical Systems Awarded Key Electroporation Patent
View Release

June 28, 2005 - Ichor Medical Systems Settlement Agreement Approved
View Release

September 4, 2003 - Ichor Medical Systems, Inc. Secures Rights to Interleukin-12 from The Wistar Institute
View Release

June 12, 2003 - Ichor Medical Systems Prevails in Equitable Assignment Judgment
View Release

May 14, 2003 - Ichor Medical Systems Awarded $13.5 Million in "Pivotal" Intellectual Property Verdict
View Release